Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Metastatic Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00125021
What this trial is testing

Tarceva and Capecitabine for Pancreatic Cancer

Who this might be right for
Pancreatic CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT06119217
What this trial is testing

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Who this might be right for
Pancreatic Cancer
Trishula Therapeutics, Inc. 194
Testing effectiveness (Phase 2)UnknownNCT05766748
What this trial is testing

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Cantex Pharmaceuticals 30
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Very early researchEnded earlyNCT00867126
What this trial is testing

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
University of Texas Southwestern Medical Center 6
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00137761
What this trial is testing

Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Carcinoma
Dana-Farber Cancer Institute 32
Early research (Phase 1)Looking for participantsNCT03454035
What this trial is testing

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Who this might be right for
Tumor, SolidPancreatic CancerMelanoma
UNC Lineberger Comprehensive Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT06625320
What this trial is testing

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT02657330
What this trial is testing

Study of SBP-101 in Pancreatic Cancer

Who this might be right for
Pancreatic CancerDuctal Adenocarcinoma of the Pancreas
Panbela Therapeutics, Inc. 29
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT04116073
What this trial is testing

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Who this might be right for
Pancreatic Cancer Non-resectablePancreatic Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT01232829
What this trial is testing

Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 18